US Stock MarketDetailed Quotes

GDTC CytoMed Therapeutics

Watchlist
  • 2.580
  • +0.210+8.86%
Close Dec 24 13:00 ET
29.77MMarket Cap-12.84P/E (TTM)

CytoMed Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CytoMed Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 8, 20242024/Q2-- / 156.000K--
--2024/Q1-- / 156.000K--
--2023/Q4-- / 130.000K--
--2023/Q3-- / 130.000K--
Nov 22, 20232023/Q2-- / 130.000K--
DatePeriodRevenue/EstimateEarnings Call
Oct 8, 20242024/Q2-- / 156.000K--
--2024/Q1-- / 156.000K--
--2023/Q4-- / 130.000K--
--2023/Q3-- / 130.000K--
Nov 22, 20232023/Q2-- / 130.000K--

Unlock Free Earnings Estimates

CytoMed Therapeutics Earnings Reports

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 30 07:03 ET

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    May 24 11:16 ET

  • CytoMed Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

    Apr 25 15:36 ET

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 24 16:19 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +1.41%
    Workday
    WDAY
    +1.38%
    Dorian LPG
    LPG
    +1.12%
    DexCom
    DXCM
    +0.88%
    Precision Drilling
    PDS
    +0.86%

    Unlock the Full List